Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 153 of the 156 references it cites were found in a registry or an index.

Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies

Open access

Abstract

BACKGROUND: Incomplete adherence to tuberculosis (TB) treatment increases the risk of delayed culture conversion with continued transmission in the community, as well as treatment failure, relapse, and development or amplification of drug resistance. We conducted a systematic review and meta-analysis of adherence interventions, including directly observed therapy (DOT), to determine which approaches lead to improved TB treatment outcomes. METHODS AND FINDINGS: We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retrospective cohort studies (CSs) with an internal or external control group that evaluated any adherence intervention and conducted a meta-analysis of their impact on TB treatment outcomes. Our search identified 7,729 articles, of which 129 met the inclusion criteria for quantitative analysis. Seven adherence categories were identified, including DOT offered by different providers and at various locations, reminders and tracers, incentives and enablers, patient education, digital technologies (short message services [SMSs] via mobile phones and video-observed therapy [VOT]), staff education, and combinations of these interventions. When compared with DOT alone, self-administered therapy (SAT) was associated with lower rates of treatment success (CS: risk ratio [RR] 0.81, 95% CI 0.73-0.89; RCT: RR 0.94, 95% CI 0.89-0.98), adherence (CS: RR 0.83, 95% CI 0.75-0.93), and sputum smear conversion (RCT: RR 0.92, 95% CI 0.87-0.98) as well as higher rates of development of drug resistance (CS: RR 4.19, 95% CI 2.34-7.49). When compared to DOT provided by healthcare providers, DOT provided by family members was associated with a lower rate of adherence (CS: RR 0.86, 95% CI 0.79-0.94). DOT delivery in the community versus at the clinic was associated with a higher rate of treatment success (CS: RR 1.08, 95% CI 1.01-1.15) and sputum conversion at the end of two months (CS: RR 1.05, 95% CI 1.02-1.08) as well as lower rates of treatment failure (CS: RR 0.56, 95% CI 0.33-0.95) and loss to follow-up (CS: RR 0.63, 95% CI 0.40-0.98). Medication monitors improved adherence and treatment success and VOT was comparable with DOT. SMS reminders led to a higher treatment completion rate in one RCT and were associated with higher rates of cure and sputum conversion when used in combination with medication monitors. TB treatment outcomes improved when patient education, healthcare provider education, incentives and enablers, psychological interventions, reminders and tracers, or mobile digital technologies were employed. Our findings are limited by the heterogeneity of the included studies and lack of standardized research methodology on adherence interventions. CONCLUSION: TB treatment outcomes are improved with the use of adherence interventions, such as patient education and counseling, incentives and enablers, psychological interventions, reminders and tracers, and digital health technologies. Trained healthcare providers as well as community delivery provides patient-centered DOT options that both enhance adherence and improve treatment outcomes as compared to unsupervised, SAT alone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002595

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 PRISMA summary. TB, tuberculosis.
Fig 1 PRISMA summary. TB, tuberculosis.CC BY · PubMed Central
Fig 2 (A) SAT compared with DOT on TB treatment outcomes. (B) Impact of any DOT provided by lay providers, family members, or healthcare workers on TB treatment outcomes. * = significant heterogeneity in the meta-analysis as determined by I2 statistic. 1 = depicted is the rate of adherence in one study defined as completing >90% of treatment doses by pill counting in one CS and based on six positive INH urine tests done at random in one RCT. Conversion = sputum conversion to negative at the end of two months (CS) and three months (RCT). N = number of studies included within the meta-analysis. Resistance = development of drug resistance. CS, cohort study; DOT, directly observed therapy; HCW, healthcare worker; INH, isoniazid; LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; SAT, self-administered therapy; TB, tuberculosis.
Fig 2 (A) SAT compared with DOT on TB treatment outcomes. (B) Impact of any DOT provided by lay providers, family members, or healthcare workers on TB treatment outcomes. * = significant heterogeneity in the meta-analysis as determined by I2 statistic. 1 = depicted is the rate of adherence in one study defined as completing >90% of treatment doses by pill counting in one CS and based on six positive INH urine tests done at random in one RCT. Conversion = sputum conversion to negative at the end of two months (CS) and three months (RCT). N = number of studies included within the meta-analysis. Resistance = development of drug resistance. CS, cohort study; DOT, directly observed therapy; HCW, healthcare worker; INH, isoniazid; LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; SAT, self-administered therapy; TB, tuberculosis.CC BY · PubMed Central
Fig 3 Funnel plot of cohort studies comparing treatment success rates in patients undergoing SAT versus DOT. No funnel plot of RCTs has been included as there were fewer than 10 RCTs. DOT, directly observed therapy; RCT, randomized controlled trial; RR, risk ratio; SAT, self-administered therapy; SE, standard error.
Fig 3 Funnel plot of cohort studies comparing treatment success rates in patients undergoing SAT versus DOT. No funnel plot of RCTs has been included as there were fewer than 10 RCTs. DOT, directly observed therapy; RCT, randomized controlled trial; RR, risk ratio; SAT, self-administered therapy; SE, standard error.CC BY · PubMed Central
Fig 4 Meta-analysis of treatment success rates in patients undergoing SAT versus DOT. DOT, directly observed therapy; M-H, Mantel-Haenszel; SAT, self-administered therapy.
Fig 4 Meta-analysis of treatment success rates in patients undergoing SAT versus DOT. DOT, directly observed therapy; M-H, Mantel-Haenszel; SAT, self-administered therapy.CC BY · PubMed Central
Fig 5 Forest plot of adherence rates in studies comparing patients undergoing SAT versus DOT. CHW, community health worker; DOT, directly observed therapy; INH, isoniazid; M-H, Mantel-Haenszel; SAT, self-administered therapy.
Fig 5 Forest plot of adherence rates in studies comparing patients undergoing SAT versus DOT. CHW, community health worker; DOT, directly observed therapy; INH, isoniazid; M-H, Mantel-Haenszel; SAT, self-administered therapy.CC BY · PubMed Central
Fig 6 Meta-analysis of rates of sputum conversion in patients undergoing SAT versus DOT. DOT, directly observed therapy; M-H, Mantel-Haenszel; RCT, randomized controlled trial; SAT, self-administered therapy.
Fig 6 Meta-analysis of rates of sputum conversion in patients undergoing SAT versus DOT. DOT, directly observed therapy; M-H, Mantel-Haenszel; RCT, randomized controlled trial; SAT, self-administered therapy.CC BY · PubMed Central
Fig 7 Meta-analysis of treatment success rates in HIV/TB patients undergoing SAT versus DOT. DOT, directly observed therapy; M-H, Mantel-Haenszel; SAT, self-administered therapy; TB, tuberculosis.
Fig 7 Meta-analysis of treatment success rates in HIV/TB patients undergoing SAT versus DOT. DOT, directly observed therapy; M-H, Mantel-Haenszel; SAT, self-administered therapy; TB, tuberculosis.CC BY · PubMed Central
Fig 8 Meta-analysis of treatment success rates in patients receiving DOT by different types of providers. DOT, directly observed therapy; HCW, healthcare worker; M-H, Mantel-Haenszel.
Fig 8 Meta-analysis of treatment success rates in patients receiving DOT by different types of providers. DOT, directly observed therapy; HCW, healthcare worker; M-H, Mantel-Haenszel.CC BY · PubMed Central
Fig 9 Comparison of adherence rates in patients receiving DOT by a family member versus HCW. DOT, directly observed therapy; HCW, healthcare worker; M-H, Mantel-Haenszel.
Fig 9 Comparison of adherence rates in patients receiving DOT by a family member versus HCW. DOT, directly observed therapy; HCW, healthcare worker; M-H, Mantel-Haenszel.CC BY · PubMed Central
Fig 10 (A) Impact of DOT provided at home, in the community, or in clinic on TB treatment outcomes. (B) Impact of patient education and counseling interventions on TB treatment outcomes. * = significant heterogeneity in the meta-analysis, as determined by I2 statistic. 1 = adherence defined as the proportion of patients that took >75% of prescribed doses in one CS and the proportion of patients attending all appointments in one RCT. Conversion = sputum conversion to negative at the end of two months. N = number of studies included within the meta-analysis. Composite outcome reported by one study defined as combined failure, default, death, or transfer out. CS, cohort study; DOT, directly observed therapy; LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; TB, tuberculosis; UO, unfavorable outcome.
Fig 10 (A) Impact of DOT provided at home, in the community, or in clinic on TB treatment outcomes. (B) Impact of patient education and counseling interventions on TB treatment outcomes. * = significant heterogeneity in the meta-analysis, as determined by I2 statistic. 1 = adherence defined as the proportion of patients that took >75% of prescribed doses in one CS and the proportion of patients attending all appointments in one RCT. Conversion = sputum conversion to negative at the end of two months. N = number of studies included within the meta-analysis. Composite outcome reported by one study defined as combined failure, default, death, or transfer out. CS, cohort study; DOT, directly observed therapy; LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; TB, tuberculosis; UO, unfavorable outcome.CC BY · PubMed Central
Fig 11 Meta-analysis of treatment success rates in patients receiving DOT in various locations. DOT, directly observed therapy; HCW, healthcare worker; M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 11 Meta-analysis of treatment success rates in patients receiving DOT in various locations. DOT, directly observed therapy; HCW, healthcare worker; M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 12 Adherence rates in patients receiving DOT at various locations. DOT, directly observed therapy; M-H, Mantel-Haenszel.
Fig 12 Adherence rates in patients receiving DOT at various locations. DOT, directly observed therapy; M-H, Mantel-Haenszel.CC BY · PubMed Central
Fig 13 Meta-analysis of sputum conversion rates at two months in patients receiving DOT at various locations. DOT, directly observed therapy; M-H, Mantel-Haenszel.
Fig 13 Meta-analysis of sputum conversion rates at two months in patients receiving DOT at various locations. DOT, directly observed therapy; M-H, Mantel-Haenszel.CC BY · PubMed Central
Fig 14 Meta-analysis of treatment success rates in patients receiving patient education and counseling interventions in addition to standard care versus standard care alone. M-H, Mantel-Haenszel.
Fig 14 Meta-analysis of treatment success rates in patients receiving patient education and counseling interventions in addition to standard care versus standard care alone. M-H, Mantel-Haenszel.CC BY · PubMed Central
Fig 15 Adherence rates in patients receiving patient education and counseling interventions in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 15 Adherence rates in patients receiving patient education and counseling interventions in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 16 (A) Impact of incentives and enablers on TB treatment outcomes. (B) Impact of reminders and tracers on TB treatment outcomes. * = significant heterogeneity in the meta-analysis as determined by I2 statistic. 1 = adherence defined as the proportion of patients who presented for all drug collections in the first six months of treatment. Conversion = sputum conversion at the end of two months. Resistance = development of drug resistance. N = number of studies included within the meta-analysis. LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; TB, tuberculosis.
Fig 16 (A) Impact of incentives and enablers on TB treatment outcomes. (B) Impact of reminders and tracers on TB treatment outcomes. * = significant heterogeneity in the meta-analysis as determined by I2 statistic. 1 = adherence defined as the proportion of patients who presented for all drug collections in the first six months of treatment. Conversion = sputum conversion at the end of two months. Resistance = development of drug resistance. N = number of studies included within the meta-analysis. LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; TB, tuberculosis.CC BY · PubMed Central
Fig 17 Meta-analysis of treatment success rates in patients receiving incentives and enablers in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 17 Meta-analysis of treatment success rates in patients receiving incentives and enablers in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 18 (A) Meta-analysis of treatment success rates in patients receiving reminders/tracers in addition to standard care versus standard care alone. (B) Sensitivity analysis: removing the heaviest weighted study (Bronner 2012) in which control and intervention cohorts had different pre-intervention success rates. M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 18 (A) Meta-analysis of treatment success rates in patients receiving reminders/tracers in addition to standard care versus standard care alone. (B) Sensitivity analysis: removing the heaviest weighted study (Bronner 2012) in which control and intervention cohorts had different pre-intervention success rates. M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 19 Adherence rates in patients receiving reminders/tracers in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 19 Adherence rates in patients receiving reminders/tracers in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 20 Meta-analysis of rates of sputum conversion at two months in patients receiving reminders/tracers in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 20 Meta-analysis of rates of sputum conversion at two months in patients receiving reminders/tracers in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 21 (A) Impact of staff education on TB treatment outcomes. (B) Impact of using psychological interventions, such as mental health counseling and support groups, on TB treatment outcomes. * = significant heterogeneity in the meta-analysis, as determined by I2 statistic. N = number of studies included within the meta-analysis. CS, cohort study; LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; TB, tuberculosis.
Fig 21 (A) Impact of staff education on TB treatment outcomes. (B) Impact of using psychological interventions, such as mental health counseling and support groups, on TB treatment outcomes. * = significant heterogeneity in the meta-analysis, as determined by I2 statistic. N = number of studies included within the meta-analysis. CS, cohort study; LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; TB, tuberculosis.CC BY · PubMed Central
Fig 22 Meta-analysis of the impact of staff education on treatment success rates. M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 22 Meta-analysis of the impact of staff education on treatment success rates. M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 23 (A) Impact of digital technologies on TB treatment outcomes. (B) Impact of combining different types of adherence interventions on TB treatment outcomes. * = significant heterogeneity in the meta-analysis, as determined by I2 statistic. 1 = defined as proportion of patients taking >90% of pills. Conversion = sputum conversion at the end of two months. N = number of studies included within the meta-analysis. Poor adherence = percentage of patient-months in which >20% of doses were missed. CS, cohort study; DOT, directly observed therapy; LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; TB, tuberculosis; VOT, video-observed therapy.
Fig 23 (A) Impact of digital technologies on TB treatment outcomes. (B) Impact of combining different types of adherence interventions on TB treatment outcomes. * = significant heterogeneity in the meta-analysis, as determined by I2 statistic. 1 = defined as proportion of patients taking >90% of pills. Conversion = sputum conversion at the end of two months. N = number of studies included within the meta-analysis. Poor adherence = percentage of patient-months in which >20% of doses were missed. CS, cohort study; DOT, directly observed therapy; LTFU, loss to follow-up; RCT, randomized controlled trial; RR, risk ratio; TB, tuberculosis; VOT, video-observed therapy.CC BY · PubMed Central
Fig 24 Meta-analysis of treatment success rates in patients receiving phone reminders in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 24 Meta-analysis of treatment success rates in patients receiving phone reminders in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 25 Rates of sputum conversion at two months in patients receiving phone reminders in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.
Fig 25 Rates of sputum conversion at two months in patients receiving phone reminders in addition to standard care versus standard care alone. M-H, Mantel-Haenszel; RCT, randomized controlled trial.CC BY · PubMed Central
Fig 26 Meta-analysis of treatment success rates in patients receiving combination adherence interventions (enhanced DOT) in addition to standard care versus standard care alone. DOT, directly observed therapy; M-H, Mantel-Haenszel; RCT, randomized controlled trial; SAT, self-administered therapy.
Fig 26 Meta-analysis of treatment success rates in patients receiving combination adherence interventions (enhanced DOT) in addition to standard care versus standard care alone. DOT, directly observed therapy; M-H, Mantel-Haenszel; RCT, randomized controlled trial; SAT, self-administered therapy.CC BY · PubMed Central
Fig 27 Adherence rates in patients receiving combination adherence interventions (enhanced DOT or enhanced SAT) in addition to standard care versus standard care alone. DOT, directly observed therapy; M-H, Mantel-Haenszel; RCT, randomized controlled trial; SAT, self-administered therapy.
Fig 27 Adherence rates in patients receiving combination adherence interventions (enhanced DOT or enhanced SAT) in addition to standard care versus standard care alone. DOT, directly observed therapy; M-H, Mantel-Haenszel; RCT, randomized controlled trial; SAT, self-administered therapy.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 156 references

Research works printed but not linked: 7

  1. Alipanah N, Jarlsberg L, Miller C, Lechner A, Wai K, Nahid P. Report for Systematic Review for Adherence Interventions in TB Treatment. World Health Organization guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017;Annex 5.
  2. 2014, Review Manager (RevMan)
  3. T Chennai, 1997, A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis, Tuberculosis Research Centre. Int J Tuberc Lung Dis, 1, 509
  4. AA Vieira, 2011, Compliance with tuberculosis treatment after the implementation of the directly observed treatment, short-course strategy in the city of Carapicuiba, Brazil, J Bras Pneumol, 37, 223
  5. VK Arora, 2003, Community mediated domiciliary DOTS execution—A study from New Delhi, Ind J Tub, 50, 143
  6. JP Cantalice Filho, 2009, Food baskets given to tuberculosis patients at a primary health care clinic in the city of Duque de Caxias, Brazil: effect on treatment outcomes, J Bras Pneumol, 35, 992
  7. RP Paramasivan, 1993, Short course chemotherapy: A controlled study of indirect default retrieval method, Ind J Tub, 40, 185

Cited by

See all 503

Metadata

Authors
Alipanah, N., Jarlsberg, L., Miller, C., Linh, N. N., Falzon, D., Jaramillo, E., & Nahid, P.
Affiliations
  • University of California, San Francisco (US)
  • World Health Organization (CH)
Corresponding author
Nahid, Payam
Venue
PLOS Medicine
Published
2018-07-03
Volume
15
Issue
7
Pages
e1002595
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2810683857
Cited by
503
References
156
Citations by year
2026: 48 · 2025: 75 · 2024: 79 · 2023: 88 · 2022: 75 · 2021: 67 · 2020: 42 · 2019: 26 · 2018: 3
FWCI
5.09
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (publishedVersion)
  • eScholarship (California Digital Library) (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
tuberculosis, medication adherence, directly observed therapy, drug-resistant tuberculosis, self-administered therapy, sputum smear conversion, treatment failure, drug resistance development, incentives, patient education, video-observed therapy, mobile phone reminders, treatment success, relapse, transmission risk, multidrug therapy, patient-provider relationship
MeSH terms
Adolescent, Adult, Antitubercular Agents, Attitude of Health Personnel, Child, Child, Preschool, Health Personnel, Humans, Infant, Infant, Newborn, Health Knowledge, Attitudes, Practice, Patient Education as Topic, Risk Factors, Self Care, Tuberculosis, Video Recording, Randomized Controlled Trials as Topic, Treatment Outcome, Telemedicine, Directly Observed Therapy, Cell Phone, Medication Adherence, Text Messaging, Observational Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. https://app.cochat.ai/papers/10.1371/journal.pmed.1002595
The paper
Alipanah, N., Jarlsberg, L., Miller, C., Linh, N. N., Falzon, D., Jaramillo, E., & Nahid, P. (2018). Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002595

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.